Novel Technologies for In Vivo Imaging (STTR [R41/R42])

The summary for the Novel Technologies for In Vivo Imaging (STTR [R41/R42]) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Novel Technologies for In Vivo Imaging (STTR [R41/R42])
	CFDA Number:	93.11393.114
	CFDA Description:	Biological Response to Environmental Health Hazards 93.114 Applied Toxicological Research and Testing
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Health Food and Nutrition Education Environment
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	PA-06-045
	Document Type:	Modification to Previous Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Nov 03, 2005
	Creation Date:	Jul 06, 2006
	Original Closing Date for Applications:	Multiple dates, see announcement.
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Dec 02, 2006
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	Information not provided
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	93.115 -- Biometry and Risk Estimation_Health Risks from Environmental Exposures

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification) Small businesses
Additional Information on Eligibility: Only United States SBCs are eligible to submit STTR applications. A small business concern is one that, at the time of award for both Phase I and Phase II STTR awards, meets all of the following criteria: 1. Is independently owned and operated, is not dominant in the field of operation in which it is proposing, has a place of business in the United States and operates primarily within the United States or makes a significant contribution to the US economy, and is organized for profit. 2. Is at least 51% owned and controlled by one or more individuals who are citizens of, or permanent resident aliens in, the United States. 3. Has, including its affiliates, an average number of employees for the preceding 12 months not exceeding 500, and meets the other regulatory requirements found in 13 C.F.R. Part 121. Business concerns are generally considered to be affiliates of one another when either directly or indirectly, (a) one concern controls or has the power to control the other; or (b) a third-party/parties controls or has the power to control both. Control can be exercised through common ownership, common management, and contractual relationships. The term
Grant Description: - The National Cancer Institute (NCI), the National Institute of Environmental Health Sciences (NIEHS), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and the National Institute of Neurological Disorders and Stroke (NINDS) invite Small Business Technology Transfer (STTR) applications from small business concerns (SBCs) for the development and delivery of novel in vivo image acquisition or enhancement technologies and methods for biomedical imaging and image-guided interventions and therapy (applications may incorporate limited pilot or clinical feasibility evaluations using either pre-clinical models or clinical studies). - This funding opportunity is primarily intended to facilitate the proof-of-feasibility, development, and delivery of novel imaging technologies for early detection, screening, diagnosis, image-guided interventions and treatments of various diseases, and, secondarily, to facilitate limited evaluation studies to show proof-of-concept and functionality. - Research partnerships among investigators in both academia and device and drug industries are encouraged to more rapidly translate and deliver completed imaging system developments.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/pa-files/PA-06-045.html http://grants.nih.gov/grants/guide/pa-files/PA-06-045.html
Grant Announcement Contact: Webmaster, NIH, Webmaster, Phone not available, Fax not available, Email FBOWebmaster@mail.nih.gov FBOWebmaster@mail.nih.gov Webmaster, NIH